President Trump confirmed during a White House briefing that the administration is “looking at reclassification” of marijuana and expects to make a determination within the next few weeks.
The discussion surfaced amid reports of a Wall Street Journal exposé on Trump’s consideration of downgrading marijuana from Schedule I to Schedule III—a move that would ease legal restrictions and criminal penalties. Polling indicates over 80% of independent voters favor such reclassification, and Trump’s aides describe it as a strategic “80‑20 cultural issue”.
This policy shift has prompted a surge in marijuana-related stocks. Major cannabis companies—and the broader industry—benefited as investors responded positively to the potential reclassification.
Time Magazine notes that while Trump previously voiced mixed views, particularly supporting medical access and states’ rights, this is a notable step toward federal reform—even if limited in scope.
Conservative voices within the Trump base are sharply divided. Figures like Matt Walsh and Steve Cortes have denounced the move, citing concerns over social decay, negative impact on youth, and public health—arguing that marijuana normalization harms community welfare and productivity.
